Kevin P Meng

Title: Kevin P Meng: Innovator in Chimeric Antigen Receptor Technology

Introduction

Kevin P Meng is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of immunotherapy, particularly through his work on chimeric antigen receptors (CARs). His innovative approach has the potential to enhance cancer treatment methodologies.

Latest Patents

Kevin P Meng holds 1 patent related to his work on chimeric antigen receptors. The patent focuses on CARs that comprise an NGK2D ecto domain. It also includes compositions, cells, and cell therapies that utilize these receptors, along with methods of treatment that could revolutionize therapeutic strategies.

Career Highlights

Kevin is currently employed at Kite Pharma, Inc., a company renowned for its advancements in cell therapy. His work at Kite Pharma has positioned him as a key player in the development of innovative cancer treatments. His expertise in CAR technology is instrumental in the ongoing research and development efforts at the company.

Collaborations

Kevin has collaborated with notable colleagues, including Jodi Murakami and Samuel T Haile. These partnerships have fostered a collaborative environment that enhances the research and development of cutting-edge therapies.

Conclusion

Kevin P Meng's contributions to the field of chimeric antigen receptor technology exemplify the impact of innovative thinking in medical science. His work continues to pave the way for advancements in cancer treatment, showcasing the importance of collaboration and creativity in research.